Comparative Outcomes of Doxorubicin and Cyclophosphamide with Sequential versus Concurrent Paclitaxel in the Adjuvant Treatment of Non-Metastatic Breast Cancer: A Cross-Sectional Analytical Study
Introduction: Studies have compared the efficacy and toxicities of doxorubicin and cyclophosphamide every three weeks for four cycles followed by four cycles of paclitaxel every three weeks (AC/T); with paclitaxel, doxorubicin, and cyclophosphamide (TAC) every three weeks for six cycles for adjuvan...
Saved in:
| Main Authors: | Bishal Paudel, Bishnudutta Paudel, Rakshya Shrestha, Bishal Panthi, Ramila Shilpakar, Soniya Dulal, Sanjeev Kharel, Reechashree Dhunagana, Yogendra Prasad Singh, Bipsana Shrestha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nepal Medical Association
2025-06-01
|
| Series: | Journal of Nepal Medical Association |
| Subjects: | |
| Online Access: | https://www.jnma.com.np/jnma/index.php/jnma/article/view/9130 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of hesperidin/hesperetin against chemotherapy-induced cardiotoxicity: a systematic review of non-clinical studies
by: Sina Shaernejad, et al.
Published: (2025-05-01) -
Menstrual and Hormonal Changes in Breast Cancer Patients Treated By Ad- juvant, Adriamycin and Cyclophosphamide Chemotherapy
by: Jangi Shawkat Muhialdin Salai, et al.
Published: (2023-01-01) -
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01) -
Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014-07-01) -
A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (9C4)
by: Naiim S. Ali, et al.
Published: (2019-01-01)